Safe use of sodium glucose co-transporter 2 inhibitors in the management of type 2 diabetes
Nursing Standard · 04.01.2023 · 38 (1) · 61-66
DOI: 10.7748/ns.2022.e11959 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nursing Standard, online erschienen am 07.11.2022. Verfasst von Georgia Noble-Bell und 1 weiteren Autor:innen. Beteiligte Einrichtung: King's College Hospital NHS Foundation Trust, London, England. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- King's College Hospital NHS Foundation Trust, London, England.
Zitieren
APA
Noble-Bell, G., & Bright-Davies, C. (2023). Safe use of sodium glucose co-transporter 2 inhibitors in the management of type 2 diabetes. Nursing Standard, 38(1), 61-66. https://doi.org/10.7748/ns.2022.e11959
Vancouver
Noble-Bell G, Bright-Davies C. Safe use of sodium glucose co-transporter 2 inhibitors in the management of type 2 diabetes. Nursing Standard. 2023;38(1):61-66. doi:10.7748/ns.2022.e11959
BibTeX
@article{NobleBell2023,
author = {Noble-Bell, Georgia and Bright-Davies, Comfort},
title = {Safe use of sodium glucose co-transporter 2 inhibitors in the management of type 2 diabetes},
journal = {Nursing Standard},
year = {2023},
volume = {38},
number = {1},
pages = {61--66},
doi = {10.7748/ns.2022.e11959}
}
EUVIMED